Latest Edition Serves as a Comprehensive Resource for Digital Novices and Experts AlikeNEWPORT BEACH, CA / ACCESSWIRE / ...

Cherwell, cleanroom microbiology solutions expert,  is pleased to announce its participation in the upcoming Pharmaceutical ...

KENOSHA, WI / ACCESSWIRE / October 1, 2024 / OccuPro, a leader in employment testing software, proudly announces the release ...

With nearly £2.9 million[1] worth of vaccines lost annually due to cold chain issues, the ongoing need for innovative and ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

DUBAI, UAE / ACCESSWIRE / October 1, 2024 / Patient outcomes are being revolutionized by cutting-edge technologies and ...

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical ...

FORT LAUDERDALE, FL, October 1, 2024 (Newswire.com) - Physicians Group, LLC's Network Of Clinics And Diverse Patient ...

AcquisitionLonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche 01.10.2024 / 16:45 CET/CEST The Vacaville site is one of the largest biologics manufacturing ...

Original-Research: Formycon AG - from First Berlin Equity Research GmbH01.10.2024 / 17:05 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group AG.The issuer is solely ...

Dr. Sugita – formerly Vice President, Head of R&D for Bristol Myers Squibb in Japan – brings nearly 20 years’ experience in R&D and commercial roles working within the Japanese businesses of global ...

Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada DENVER, CO / ACCESSWIRE / ...